KCS Wealth Advisory: NFLX position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of KCS Wealth Advisory on NFLX, newest first. How the timeline and the estimate are built.
KCS Wealth Advisory held 630 NFLX shares at 2023-09-30 per its 13F-HR filed 2023-11-03.
the latest 13F is the newest step
- period ended2023-09-3013F 630 sharesChange vs previous 13F -235 shares
0.1% of the 13F portfolio, value $237,888.
13F-HR 0001085146-23-004067 filed by KCS Wealth Advisory
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2023-06-3013F 865 sharesChange vs previous 13F -634 shares
0.13% of the 13F portfolio, value $381,024.
13F-HR 0001085146-23-002737 filed by KCS Wealth Advisory
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2023-03-3113F 1,499 sharesChange vs previous 13F -247 shares
0.2% of the 13F portfolio, value $517,875.
13F-HR 0001085146-23-001729 filed by KCS Wealth Advisory
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2022-12-3113F 1,746 sharesChange vs previous 13F -150 shares
0.21% of the 13F portfolio, value $514,860.
13F-HR 0001085146-23-000755 filed by KCS Wealth Advisory
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2022-09-3013F 1,896 sharesChange vs previous 13F +614 shares
0.21% of the 13F portfolio, value $446,000.
13F-HR 0001085146-22-003532 filed by KCS Wealth Advisory
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2022-06-3013F 1,282 sharesChange vs previous 13F not available
0.1% of the 13F portfolio, value $224,000.
13F-HR 0001085146-22-002517 filed by KCS Wealth Advisory
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).